Armata Pharmaceuticals, Inc. (ARMP) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -5.78M | -6.67M | -4.3M | -7.21M | -7.58M | -7.93M | -8.86M | -10.18M | -10.58M | -8.11M | -9.69M | -12.06M |
| Operating CF Margin % | -732.83% | - | - | -332.46% | -1543.79% | -641.86% | -298.12% | - | -1095.65% | -530.5% | -790.78% | -1230.61% |
| Operating CF Growth % | 23.72% | 15.81% | 51.51% | 29.14% | 28.38% | 2.21% | 8.51% | 15.61% | 39.76% | 22.69% | 6.25% | -48.01% |
| Net Income | -115.35M | -124.3M | -26.68M | -16.3M | -6.53M | 2.6M | -5.48M | 8.99M | -25.02M | -19.85M | -31.16M | -3.55M |
| Depreciation & Amortization | 457K | 418K | 370K | 366K | 377K | 380K | 313K | 315K | 317K | 293K | 221K | 228K |
| Stock-Based Compensation | 1.07M | 632K | 622K | 575K | 781K | 354K | 670K | 1.33M | 534K | 193K | -373K | 261K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.86M | 0 |
| Other Non-Cash Items | 107.13M | 116.61M | 19.57M | 10.14M | -1.01M | -12.45M | -3.32M | -20.15M | 15.28M | 11.06M | 17.67M | -6.04M |
| Working Capital Changes | 899K | -33K | 1.81M | -2M | -1.2M | 1.19M | -1.05M | -661K | -1.69M | 197K | 92K | -2.97M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -352K | -310K | 794K | -265K | -553K | -1.72M | 0 | -654K | -1.49M | 0 | -437K | 1.46M |
| Cash from Investing | -63K | -52K | -242K | -149K | -99K | 77K | -340K | -1.37M | -250K | -2.39M | -3.51M | -222K |
| Capital Expenditures | -63K | -52K | -242K | -149K | -99K | 77K | -340K | -1.37M | -250K | -2.4M | -3.51M | -222K |
| CapEx % of Revenue | 7.98% | - | - | 6.87% | 20.16% | 6.23% | 11.44% | - | 25.88% | 157.07% | 286.69% | 22.65% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10K | 0 | 0 |
| Cash from Financing | 641K | 658K | 14.97M | 0 | 9.99M | 0 | -61K | 88K | 34.93M | -43K | 24.8M | -368K |
| Debt Issued (Net) | 0 | 0 | 15M | 0 | 10M | -34.89M | 0 | 0 | 34.89M | 0 | 24.8M | -368K |
| Equity Issued (Net) | 704K | 658K | 0 | 0 | -14K | 0 | -61K | 88K | 42K | -43K | 5K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -14K | 0 | -61K | 0 | 0 | -43K | 0 | 0 |
| Other Financing | -63K | 0 | -32K | 0 | 0 | 34.89M | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -5.2M | -6.07M | 10.43M | -7.36M | 2.31M | -7.85M | -9.26M | -11.46M | 24.34M | -10.54M | 11.61M | -12.65M |
| Free Cash Flow | -5.84M | -6.73M | -4.54M | -7.36M | -7.68M | -7.85M | -9.2M | -11.54M | -10.83M | -10.51M | -13.2M | -12.28M |
| FCF Margin % | -740.81% | - | - | -339.33% | -1563.95% | -635.63% | -309.55% | - | -1121.53% | -687.57% | -1077.47% | -1253.27% |
| FCF Growth % | 23.88% | 14.32% | 50.67% | 36.24% | 29.12% | 25.28% | 30.28% | 6.02% | 44.67% | -4.75% | -13.52% | -32.29% |
| FCF per Share | -0.16 | -0.19 | -0.13 | -0.20 | -0.21 | -0.13 | -0.25 | -0.20 | -0.30 | -0.29 | -0.37 | -0.34 |
| FCF Conversion (FCF/Net Income) | 0.05x | 0.05x | 0.16x | 0.44x | 1.16x | -3.05x | 1.62x | -1.13x | 0.42x | 0.41x | 0.31x | 3.40x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |